Researchers
Srdić-Rajić, Tatjana
Type
- 102 Conference Paper
- 82 Article
- 1 Book parts
- 1 Other
- 1 Patent
Date issued
- 184 2000 - 2027
- 3 1000 - 1999
Results 21-40 of 187
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design![]() | Beljkaš, Milan | Article | 21aM21a |
| 2024 | Arthrospira platensis Protein Hydrolysates as A Promising Alternatives to Serum in Animal-Cell Culture![]() | Sibinčić, Nikolina | Conference Paper | Mp. category will be shown later |
| 2023 | Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical study![]() | Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Abstract 2476: Nischarin is a potential druggable target in both epithelial and stromal compartments of pancreatic ductal adenocarcinoma![]() | Grahovac, Jelena | Conference Paper | Mp. category will be shown later |
| 2023 | Nischarin expression may have differing roles in male and female melanoma patients![]() | Ostojić, Marija | Article | 21M21 |
| 2023 | Sulforaphane affects morphological changes and cell viability of colon cancer cells: p53 mutation-dependent effect![]() | Đurić, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | Synthesis, characterization, and in vivo evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes![]() | Nasiri Sovari, Sara; Kolly, Isabelle; Schindler, Kevin; Djurić, Ana | Article | 21aM21a |
| 2023 | Toxicity testing of D, L-sulforaphane in a zebrafish model![]() | Pavić, Aleksandar | Conference Paper | Mp. category will be shown later |
| 2023 | Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2023 | Antiproliferative effect of tubastatin A on vemurafenib sensitive and resistant A375 melanoma cells![]() | Vuletić, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma![]() | Nemanja Djokovic | Article | 21M21 |
| 2022 | Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients![]() | Martinovic, Mirjacic Katarina | Article | 22M22 |
| 2022 | Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion![]() | Pavlovic, Marijana | Conference Paper | Mp. category will be shown later |
| 2022 | Cationic amphiphilic drugs as potential anticancer therapy for PDAC![]() | Živanović, Marija | Conference Paper | Mp. category will be shown later |
| 2022 | Identification of novel 1-benzhydryl-piperazine derivatives as Histone Deacetylase inhibitors using Fragment-based drug design strategy![]() | Ružić, Dušan | Other | Mp. category will be shown later |
| 2022 | Antibody VH domain sequence analysis by a bioinformatics approach based on electronic amino acid properties may help to predict paratop location![]() | Srdić-Rajić, Tatjana | Article | 22M22 |
| 2022 | Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics![]() | Đoković, Nemanja | Article | 21aM21a |
| 2022 | Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinoma![]() | Ostojić, Marija | Conference Paper | Mp. category will be shown later |
| 2022 | Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6![]() | Ružić, Dušan | Conference Paper | Mp. category will be shown later |
